SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves steep selloff is fueling debate over its debt load, high financing costs and ability to fund AI-infrastructure expansion; bearish traders see refinancing and dilution risks, while bullish traders point to contracted demand and continued AI growth. Goldmans Buy upgrade and ARKs purchases have not eased the communitys concern about the financing outlook.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs steep decline to fresh lows is being linked by traders to Trumps falling approval and approaching midterms, with many expressing concern that weakening political support is hurting the stocks sentiment-driven appeal. Some see the selloff as a buying opportunity, but bearish reactions dominate.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Ciphers sharp selloff is being tied mainly to its convertible-note financing and the resulting dilution and debt concerns, alongside a broader retreat in AI data-center and neocloud stocks amid scrutiny of financing costs. Traders are frustrated with management and fear further downside, while some argue the financing overhang is easing and continue to cite long-term AI-hosting demand as a reason to buy the dip.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs upcoming Q3 earnings report is the main focus, with traders debating whether slowing growth and engagement concerns will weigh on results and guidance. Views are split: some expect further downside, while others see pessimism and recent cost and content-leadership changes as reasons for optimism.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is drawing attention after a steep selloff in memory stocks, amid weakness in South Koreas market and concerns about Chinese competitor CXMT, AI spending and memory-cycle normalization. Traders are divided between viewing the decline and rebound as a buying opportunity given the companys fundamentals and valuation, and expecting more downside from foreign selling and continued sector pressure.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

Attention centers on Uniteds upcoming quarterly results after a sharp recent selloff, with traders debating whether demand and guidance can offset elevated fuel costs. A separate wave of criticism over CEO Scott Kirbys inheritance-tax remarks has prompted boycott and sell calls, though any business or market impact remains speculative.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

KTOS is drawing attention for its prolonged selloff and repeated lows, despite defense-contract news and bullish analyst coverage. Traders debate whether the decline reflects sector pressure and an expensive valuation, alongside dilution and insider-sale concerns, or creates an opportunity based on Kratoss longer-term drone and defense growth prospects.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A steep semiconductor selloff, amid concerns about AI spending, financing risks, and whether chip demand can justify the investment boom, has driven attention to SOXL; the funds sharp rebound has sparked a divide between dip buyers expecting a recovery and traders who see a temporary bounce before further declines. The leveraged ETF amplifies the sectors swings, and traders are watching upcoming earnings and spending commentary for evidence that AI demand remains robust.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Ahead of SpaceXs Q3 report, traders are focused on whether AI-compute investment can drive revenue growth and profitability; optimism about AI and Starlink expansion is countered by concerns about heavy spending and upcoming share unlocks. Musks pledge to give a SpaceX share to every U.S. child is also drawing attention, though implementation details remain unclear.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

A prolonged semiconductor selloff has put SOXX in focus, with traders debating whether doubts about AI spending returns, inflation and crowded positioning point to a deeper correction or an oversold bounce. Bears warn the AI trade may be unwinding, while bulls argue chip demand remains strong and the pullback could be temporary.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Small-Cap ETFs Beat S&P 500 in 2026: Can the Rally Last?

Small-cap ETFs are beating the S&P 500 in 2026. Will the rally continue? Here's what valuations, earnings and macro trends say.

MLTX Stock Clocks Best Day In Over 6 Months — What’s Driving The Investor Optimism? 

Equity

Clear Street described sonelokimab’s profile in hidradenitis suppurativa as highly competitive and one that readily supports “blockbuster potential.”


MLTX Stock Moves Higher As Traders Position For Late-Stage Trial Catalysts

Moonlake’s lead drug Sonelokimab is being tested across inflammatory conditions, with the biggest near-term focus on hidradenitis suppurativa. 

ONDS Stock Rises Following Acquisition Of Israel-Based Sentry CS

Ondas expects the transaction to close in November 2025, and the terms of the deal have not been disclosed.


Time to fade momentum trade, Jefferies says

Investing.com -- The momentum factor weakened in December, but more downside can be expected in the first quarter, according to a Jefferies strategist.

Aquestive Therapeutics Pushes Retail Sentiment Into ‘Extremely Bullish’ Zone On OAS Drug Trial Success

This study marks the final supportive adult trial in the Anaphylm development program ahead of discussions with the U.S. FDA.

Invesco Exchange-Traded Fund Trust II - Invesco Dorsey Wright SmallCap Momentum ETF

Neutral Sentiment

<ul class="summary-bullets"><li>The comments followed MoonLake’s release of final Week 52 results from its two pivotal late-stage trials in adults with moderate-to-severe hidradenitis suppurativa.</li><li>MoonLake plans to submit its approval application to the FDA by the end of September.&nbsp;</li><li>Retail investors are now awaiting the data from the company’s trials in psoriatic arthritis.</li></ul> Shares of MoonLake Immunotherapeutics (MLTX) surged 15% on Monday, fueled by strong investor reaction to one-year clinical data on sonelokimab for hidradenitis suppurativa and a bullish note from Clear Street.The stock clocked its best day since early January.<h2 class="st-heading-2">Clear Street Sees ‘Blockbuster Potential’ For MoonLake Drug</h2>Clear Street described the drug’s profile in the skin condition as highly competitive and one that readily supports “blockbuster potential.” The firm kept its ‘Buy’ rating and $70 price target, noting the biologics license application remains on track for a September 30 filing and that management still sees priority review from the U.S. Food and Drug Administration as possible.The comments followed MoonLake’s release of final Week 52 results from its two pivotal late-stage trials in adults with moderate-to-severe hidradenitis suppurativa. Hidradenitis suppurativa is a chronic, painful inflammatory skin condition that causes recurring boils, abscesses, and tunneling wounds, mainly in the armpits, groin, and other skin folds.<h2 class="st-heading-2">MLTX Trial Outcome</h2>Roughly two-thirds of patients in the trials achieved at least a 75% reduction in painful abscesses and nodules without worsening elsewhere, while about one-third reached complete clearance of those lesions, MoonLake said. Around one-quarter hit full inflammatory remission. The outcomes improved further from earlier readouts and compared favorably with results seen for competing treatments at similar time points. Patients also reported meaningful gains in quality of life and pain relief.Safety stayed consistent and favorable through one year, with no new issues. Most patients opted to continue in an open-label extension, and early data from adolescents looked encouraging as well, the company said.MoonLake plans to submit its approval application by the end of September, including data from both adults and teens.<h2 class="st-heading-2">How Did MLTX Retail Traders React?</h2>On Stocktwits, retail sentiment around MLTX stock jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.A Stocktwits user expressed optimism for the company’s market capitalization rising as much as $5 billion by year's end, following the submission of an application to the FDA and a priority review. The company currently has a market cap of about $1.63 billion<stembedurl>https://www.stocktwits.com/IronManResurrection/message/657099192</stembedurl>Another user highlighted the company’s other near-term catalysts, including data from two late-stage studies of sonelokimab in psoriatic arthritis. The primary results from the two trials are expected in mid-2026 and in the second half of 2026, respectively.<stembedurl>https://www.stocktwits.com/thezat/message/657088197</stembedurl>According to data from Koyfin, 11 of the 15 analysts covering MLTX rate it ‘Buy’ or higher, while two rate it ‘Hold’ and two ‘Sell.’ The stock has a 12-month average price target of $27.62, which represents a potential upside of about 25% from the stock’s last close.<a href="https://stocktwits.com/symbol/MLTX">MLTX stock</a> has gained 84% this year.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/entx-stock-on-track-for-best-day-in-over-5-years-whats-driving-rally/cZKM5L5R79E">ENTX Stock On Track For Best Day In Over 5 Years — What’s Driving The Rally?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a MoonLake Immunotherapeutics company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Clear Street described sonelokimab’s profile in hidradenitis suppurativa as highly competitive and one that readily supports “blockbuster potential.”

Invesco Dorsey Wright SmallCap Momentum ETF

MoonLake Immunotherapeutics

Vanguard Health Care ETF

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Stocktwits

Meta Platforms Inc

Which earnings release are you most looking forward to this week: 

Feed

News

Sentiment

Fundamentals

Info

DWAS Invesco Dorsey Wright SmallCap Momentum ETF

Fundamentals

Latest DWAS News